Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02471846
Title A Study of GDC-0919 and MPDL3280A Combination Treatment in Participants With Locally Advanced or Metastatic Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Genentech, Inc.
Indications

bladder urothelial carcinoma

stomach cancer

Advanced Solid Tumor

head and neck cancer

triple-receptor negative breast cancer

renal cell carcinoma

melanoma

lung non-small cell carcinoma

Therapies

GDC-0919

Atezolizumab

Age Groups: adult
Covered Countries USA


No variant requirements are available.